Calpain 10 and type 2 diabetes: are we getting closer to an explanation?
Authors:
- Martin RidderstråleMRMartin Ridderstråle
- Hemang ParikhHPHemang Parikh
- Leif GroopLGLeif Groop
- 1 July 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 8 (4) , 361-366
Abstract
A variation in the gene encoding the cysteine protease calpain 10 (CAPN10) was recently linked and associated with type 2 diabetes by positional cloning. This positional cloning was a follow-up investigation to the identification of a diabetes-linked region on human chromosome 2 identified by genome-wide scanning a few years earlier. In this paper we give a general background on the genetic studies performed on CAPN10 to date, and review the most recent studies on the functional role of calpain 10. A haplotype or haplotype combination comprising three intronic single nucleotide polymorphisms (UCSNP-43, 19, and 63) were associated with a threefold increased risk of type 2 diabetes in the population in which linkage was first found. Another polymorphism, UCSNP-44, which is in linkage disequilibrium with a coding single-nucleotide polymorphism (Thr504Ala), has subsequently been associated with type 2 diabetes in extensive meta-analyses. Meanwhile, initial studies probing the possible role of calpain-10, completely unknown at the time, are now being pursued, both in isolated cells and humans. The positional cloning of CAPN10 as a candidate gene for type 2 diabetes has been particularly fruitful. Not only has it identified an important and surprising piece of the puzzle underlying the development of diabetes, but it has also modelled and paved the way for investigations concerning complex genetic diseases other than type 2 diabetes.Keywords
This publication has 42 references indexed in Scilit:
- Variants Within the Calpain-10 Gene on Chromosome 2q37 (NIDDM1) and Relationships to Type 2 Diabetes, Insulin Resistance, and Impaired Acute Insulin Secretion Among Scandinavian CaucasiansDiabetes, 2002
- Variation in Three Single Nucleotide Polymorphisms in the Calpain-10 Gene Not Associated With Type 2 Diabetes in a Large Finnish CohortDiabetes, 2002
- Haplotype Combinations of Calpain 10 Gene Polymorphisms Associate With Increased Risk of Impaired Glucose Tolerance and Type 2 Diabetes in South IndiansDiabetes, 2002
- Role of Calpain-10 Gene Variants in Familial Type 2 Diabetes in CaucasiansThe Journal of Clinical Endocrinology & Metabolism, 2002
- Variation in the Calpain-10 Gene Affects Blood Glucose Levels in the British PopulationDiabetes, 2002
- Type 2 Diabetes and Three Calpain-10 Gene Polymorphisms in Samoans: No Evidence of AssociationThe American Journal of Human Genetics, 2001
- Studies of Association between the Gene for Calpain-10 and Type 2 Diabetes Mellitus in the United KingdomThe American Journal of Human Genetics, 2001
- Absence of Association of Type 2 Diabetes With CAPN10 and PC-1 Polymorphisms in Oji-CreeDiabetes Care, 2001
- A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistanceJournal of Clinical Investigation, 2000
- A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2Nature Genetics, 1996